The University of Wisconsin’s patent-licensing arm must pay Washington University in St. Louis, its former partner in medical research, $31.6 million for breaching a royalties contract related to the sale of an AbbVie Inc. kidney-disease drug.
The judgment, issued Nov. 26 alongside a sealed opinion in federal court in Wilmington, Del., marks the culmination of a rare legal fight involving two universities that had formed a patent-licensing deal with a corporation.
The dispute has its roots in the early 1990s, when researchers at Washington University and Wisconsin began collaborating on treatments of conditions associated with kidney disease. The scientists applied ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.